Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Statement of Cash Flows [Abstract]    
NET LOSS $ (20,405) $ (279,450)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of ReadyOp software platform 10,878 48,897
Amortization of ReadyOp customer list 8,046
Amortization of ReadyMed software platform 138,082
Depreciation expense 150
Provision (Recovery) for bad debt (13,335) 22,000
(Increase) decrease in assets:    
Accounts receivable 49,176 (75,011)
Inventory 13,042 9,106
Prepaid expenses and other current assets 15,000 (10,000)
Due from related party (13,420)
Other assets 8,656
Assets from discontinued operations 9,929 (3,051)
Increase (decrease) in liabilities:    
Accounts payable (28,019) (15,927)
Accrued expenses (68,756) (3,403)
Deferred revenue (142,091) 140,207
Customer deposit 14,000
Liabilities from discontinued operations 2,486 64,260
Net Cash Provided by (Used in) Operating Activities (38,627) (80,326)
Cash Flows From Investing Activities    
Purchase of fixed assets (9,029)
Issuance of note receivable (25,000)
Issuance of note receivable - discontinued operations 25,000
Repayment of note receivable - discontinued operations (25,000)
Net Cash Used in Investing Activities (34,029)
Cash Flows From Financing Activities    
Proceeds from issuance of installment loan-discontinued operations 43,600 43,810
Repayment of installment loan - discontinued operations (33,151) (26,966)
Proceeds from notes payable stockholders 713
Proceeds from notes payable 156,727
Repayment of note payable (50,000)
Repayment of notes payable stockholders (20,732)
Proceeds from loan payable - related party - discontinued operations 11,362
Proceeds from issuance of common stock 100,000
Dividends paid (7,204)
Net Cash Provided by Financing Activities 107,806 110,353
Net Increase In Cash 35,150 30,027
Cash at beginning of period 27,698 413
Cash at end of period 62,848 30,440
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 4,433 4,771
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Operating lease asset obtained for operating lease liability from discontinued operations 75,078
Common stock issued for ReadyMed Platform 600,000
Deconsolidation of Voiceinterop, Inc. 225,316  
Common stock issued for conversion of note payable, accrued interest and accrued dividends - related parties $ 94,506